Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.900
+0.050 (2.70%)
At close: Jul 15, 2026, 4:00 PM EDT
1.893
-0.007 (-0.39%)
After-hours: Jul 15, 2026, 7:51 PM EDT
Allogene Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
152
Market Cap
655.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 22.00K | -73.00K | -76.84% |
| Dec 31, 2023 | 95.00K | -61.00K | -39.10% |
| Dec 31, 2022 | 156.00K | -113.93M | -99.86% |
| Dec 31, 2021 | 114.09M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALLO News
- 17 hours ago - Allogene publishes Phase 1 data in Journal of Clinical Oncology - TheFly
- 18 hours ago - Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors - GlobeNewsWire
- 15 days ago - Allogene Therapeutics Transcript: H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - Transcripts
- 27 days ago - Allogene Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Allogene Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Allogene Therapeutics says Zachary Roberts to succeed David Chang as CEO - TheFly
- 6 weeks ago - Allogene Therapeutics Announces Planned CEO Succession - GlobeNewsWire
- 6 weeks ago - Allogene Therapeutics Proxy statement: Proxy filing - Filings